Orion Corporation v. Alembic Pharmaceuticals Limited

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Unassigned Judge · 2,770 cases in index

Docket number

1:25-cv-00825

Cause

35:1 Patent Infringement
35 U.S.C. § 1

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

07/03/2025

1,113 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Orion Corporation Commercial & Industrial Construction · 26 cases
• defendant · Alembic Pharmaceuticals Limited · 21 cases

Part of a Larger Litigation Pattern

This is one of 22 Patent - ANDA cases in our index naming ALEMBIC PHARMACEUTICALS LIMITED — a possible mass-tort or coordinated-litigation cluster.

• Actelion Pharmaceuticals US, Inc v. Alembic Pharmaceuticals Limited
  District Court, D. DelawareFiled 04/04/2023
• Adverio Pharma Gmbh v. Alembic Pharmaceuticals Limited
  District Court, D. New JerseyFiled 03/07/2023
• Galderma Laboratories, L.P v. Alembic Pharmaceuticals Limited
  District Court, D. DelawareFiled 10/05/2022
• Celgene Corporation v. Alembic Pharmaceuticals Limited
  District Court, D. New JerseyFiled 11/18/2021
• AstraZeneca Ab v. Alembic Pharmaceuticals Limited
  District Court, D. DelawareFiled 07/02/2021
• Amgen Inc v. Alembic Pharmaceuticals Limited
  District Court, D. DelawareFiled 01/20/2021

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Orion Corporation v. Alembic Pharmaceuticals Limited?

Orion Corporation v. Alembic Pharmaceuticals Limited is a federal patent - anda lawsuit filed on 07/03/2025 in the District Court, D. Delaware. The case is currently open in the federal court system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:25-cv-00825.

When was the case filed?

Orion Corporation v. Alembic Pharmaceuticals Limited was filed on 07/03/2025. The case is currently open.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 1.